|
E-mail this page to a friend!
Elder Care News
New UK Study Finds Lack of Care for Older Breast
Cancer Patients
U.S. study in 2000 found less aggressive cancer and
treatment in elderly women; another last year found elderly not getting
exams
March
29, 2007 - Compared to younger women, older women with breast cancer are
less likely to be diagnosed via needle biopsy and triple assessment,
less likely to undergo surgery and less likely to receive radiotherapy,
say researchers in this week's British Journal of Cancer. Such
management of older women is likely to lead to higher rates of local
recurrence of the disease and higher than necessary mortality. A U.S.
study in 2000 also found less aggressive treatment of elderly patients
and another last year says elderly not being given breast exams.
(See report on 2000 study below
this report and report on lack of breast exams for elderly in sidebar.)
"We
have found that older women from aged 70 and over are less likely to
receive the same breast cancer care as younger women and that this is
related to their age rather than differences in the biology of their tumour,"
says Dr Katrina Lavelle, who led the study at the University's School of
Nursing, Midwifery and Social Work.
The highest incidence of breast cancer in England
occurs in women aged 70 years and older. Older women also experience the
worst survival - women aged 70-79 have a 76% five-year relative survival
compared to 80% for all ages, and for women aged 80 plus this drops
considerably to 61%, beyond what might be expected owing to an increase
in age.
The team carried out a retrospective cohort study
involving case note review based on the North Western Cancer Registry
database of women aged 65 and over, resident in Greater Manchester with
invasive breast cancer registered over a one year period.
The results of the study, funded by an NHS R&D
Training Fellowship, may be generalized nationally as variation in
survival between regions is lower for breast cancer compared to other
cancers.
They found that, compared to women aged 65-69
years, women aged 80 plus with operable breast cancer have increased
odds of not receiving triple assessment, not receiving primary surgery,
not undergoing axillary node surgery and not undergoing steroid receptor
tests (which indicate suitability for hormone therapy).
Compared with her 65-69-year-old counterpart, the
odds of a woman aged 80 or older not receiving triple assessment for
operable breast cancer are five-and-a-half times higher, and the odds of
her not receiving surgery are more than 40 times higher.
| |
Risk of Breast Cancer by Age in
U.S.
Centers for Disease Control and
Prevention:
Breast Cancer
The risk of getting breast cancer
increases with age. The table below shows the percentage of
women (how many out of 100) who will get breast cancer over
different time periods. The time periods are based on the
person's current age.
For example, go to current age 60. The
table shows 3.7% of women who are now 60 years old will get
breast cancer sometime during the next 10 years. That is, 3 to 4
out of every 100 women who are 60 years old today will get
breast cancer by the age of 70.
Percent of U.S. Women Who Develop
Breast Cancer Over 10-, 20-, and 30-Year Intervals
According to Their Current Age, 2001–2003*
|
Current Age |
10
Years |
20
Years |
30
Years |
|
30 |
0.4 |
1.9 |
4.4 |
|
40 |
1.4 |
4.0 |
7.3 |
|
50 |
2.6 |
6.0 |
9.3 |
|
60 |
3.7 |
7.1 |
9.1 |
|
70 |
4.0 |
6.3 |
N/A |
*Source: Data are from 17 Surveillance, Epidemiology, and End
Results (SEER) registries covering 25% of the U.S. population.
Age-specific data are not available for women over 95 years old. DevCan database, National Cancer Institute.
Deaths from Breast Cancer by Age
The risk of dying from breast cancer
increases with age. The table below shows the percentage of
women (how many out of 100) who will die from breast cancer over
different time periods. The time periods are based on the
person's current age.
For example, go to current age 60. The
table shows 0.7% of women who are now 60 years old will die from
breast cancer during the next 10 years. That is, about 1 woman
out of 100 women who are 60 years old today will die from breast
cancer by the age of 70.
Percent of U.S. Women Who Die from Breast
Cancer Over 10-, 20-, and 30-Year Intervals
According to Their Current Age, 2001–2003*
|
Current Age |
10
Years |
20
Years |
30
Years |
|
30 |
0.1 |
0.3 |
0.7 |
|
40 |
0.2 |
0.6 |
1.3 |
|
50 |
0.4 |
1.1 |
1.9 |
|
60 |
0.7 |
1.5 |
2.2 |
|
70 |
0.9 |
1.8 |
N/A |
*Source: Data are from
National Center for Health Statistics (NCHS). Age-specific data
are not available for women over 95 years old. DevCan database,
National Cancer Institute.
Date last reviewed:
09/28/2006
Content source:
Division of Cancer Prevention and Control,
National Center for Chronic Disease Prevention
and Health Promotion |
|
Even women as young as 70-74 have over 7 times the
odds of not receiving radiotherapy following breast conservation surgery
compared to women aged 65-69 years.
In addition, the team discovered that the overall
percentage of women in all the age groups not receiving steroid receptor
tests was high at 41%, which resulted in treatment decisions being taken
without this fundamental information.
Three quarters of the patients who did not receive
steroid receptor tests were given the hormone therapy, tamoxifen: that
is, prescribed a treatment without evidence that it would work.
In a survey of UK breast cancer surgeons in 2004,
75% reported that they would treat older breast cancer patients in a
similar way to younger patients and 98% responded that the cut off point
for breast cancer surgery was not age related.
Dr Lavelle says, "Clearly there is a difference in
clinicians' perceptions of how older breast cancer patients should be
treated and their actual practice.
"Standard management of breast cancer was
infrequent in older women in Greater Manchester. The lack of diagnostic
and steroid receptor testing resulted in older cancer patients having no
effective treatment with 41% not undergoing a steroid receptor test, 32%
of whom received tamoxifen as their sole form of treatment.
"Mortality of elderly breast cancer patients is
unlikely to improve where this pattern of management persists."
Research lead for the School of Nursing, Midwifery
and Social Work, Professor Chris Todd, commented: "It would be wrong to
conclude that ageism is to be found in the NHS on the basis of these
results alone, as this study has not been able to take the preferences
of older women themselves into account. This is something we intend to
investigate in the next phase of our research."
Editor's Notes:
Women in England aged 70, 75 and 80 years old
currently have life expectancies of 16.0, 12.2 and 9.0 respectively.
Moreover, life expectancy is increasing.
The life expectancy of 80 year old woman is
expected to rise to 11.0 years by the year 2027. Therefore, older women
who survive their breast cancer can currently be expected to live for a
considerable time and this will increase in the future.
See
http://www.gad.gov.uk/Life_Tables/docs/2004/20045yrEngperiod1981web.xls
Women aged 80 years and older currently represent
5.7% of the female population in England (1.5 million people). As the
proportion of older people in the population is increasing, the
percentage of women in England aged 80 and over, is expected to rise to
7.6% (2.1 million people) by 2027 and more than double to 12.5% (3.8
million people) by the year 2071. We can therefore expect the number of
cases of breast cancer in older people to increase over the next 60
years.
See
http://www.gad.gov.uk/Population/2004/england/weng045y.xls
'Non-standard management of breast cancer increases
with age in the UK: a population based cohort of women aged 65 years and
above' is published in the British Journal of Cancer. The study received
ethical approval from the NW Multicentre Research Ethics Committee (MREC/01/8/62).
The NW Cancer Intelligence Service (previously the
North Western Cancer Registry) provided computing and administrative
support and the clinicians, administration staff and patients at the
participating hospitals.
The University of Manchester's Faculty of Medical
and Human Sciences receives almost a third of the University's total
research income. There are 7,600 undergraduate students and 1,600
postgraduates on award-bearing courses. More students graduate each year
from the School of Medicine than from any other medical school in the
UK. For more information see
http://www.manchester.ac.uk/
U.S. Study Says Breast Cancer and Treatment Less
Aggressive in Elderly Women
Read complete report at
American Cancer Society, click here
The American Cancer Society reports on a study in
2000 that found older women tend to have less aggressive breast cancers
than younger women. It found, too, that women with lymph-node negative
breast cancer older than 70 survive as long as their contemporaries
without breast cancer. But, they also found a lack of treatment for
these elderly patients.
The researchers found elderly patients were less
likely to receive systemic chemotherapy and radiation therapy and that
they undergo less extensive surgery than younger patients. Older
patients were just as likely as younger patients to receive systemic
hormone therapy but, because older patients are more likely to have
tumors with steroid hormone receptors, the researchers suggest greater
numbers of them might be expected to have adjuvant endocrine therapy.
"It is not clear whether age was a factor in the
decision regarding adjuvant endocrine therapy," the researchers write.
"It is unfortunate that the majority of clinical trials that addressed
surgical, radiation and systemic therapies have not included older
patients."
The study authors say more research is needed into
treatment for elderly breast cancer patients. "The best approaches to
local and systemic therapies in elderly patients and the impact of each
modality in therapy on the natural history of the disease and the
quality of life require evaluation in clinical trials," they write.
"Because older patients with small tumors are more
likely to die of non-breast-cancer conditions and because screening
mammography detects small tumors that are more likely to be lymph node
negative, it is possible that screening mammography might have limited
value in older patients," the authors write.
The American Cancer Society (ACS), however, still
recommends annual mammography for these women.
"The American Cancer Society does not put an upper
limit on its screening recommendations and advises all women older than
40 to have an annual screening mammogram," says Harmon Eyre, MD, chief
medical officer for the ACS. "We would not change our guidelines based
on the results of one study."
A women should consider her overall health when
making a decision about having mammography, Dr. Eyre adds. "If an older
patient has health problems that keep her from being a candidate for
breast cancer treatment, then mammography may not have great value to
her," he says. "However, if an elderly patient is otherwise in good
health, then breast cancer could be easily detected with a mammography
and treated."
"This study clearly demonstrates that breast cancer
in the elderly has distinctive biologic and clinical characteristics,"
writes Sami G. Diab, MD, of the Rocky Mountain Cancer Centers in Aurora,
Colo., and colleagues in the April 5, 2000 issue of the Journal of the
National Cancer Institute.
The US population is aging, and the risk of breast
cancer increases with age. Changing demographics will lead to more cases
of breast cancer in women age 65 or older, according to the study.
The team found older patients tend to have tumors
with features previously shown to correlate with less aggressive growth
and spread. For example, both databases show the percentage of patients
with tumors that have estrogen receptors increases with age. The older
patients also tended to have tumors with favorable genetic
characteristics ? including normal p53 and low or undetectable levels of
epidermal growth factor receptor and c-erbB2.
The researchers reviewed the records of 50,828
patients with invasive breast cancer from San Antonio databases and
256,287 patients from the Surveillance, Epidemiology and End Results
registry, which is a collection of nine US cancer registries that
collect and submit data to the National Cancer Institute.
>>
More about breast cancer at MedlinePlus
|
Nursing Home Abuse, Medical Malpractice? Contact a lawyer.
click here
|
|
Click to More Senior News on the
Front Page
Copyright: SeniorJournal.com |